ESTRO 2023 - Abstract Book

S97

Saturday 13 May

ESTRO 2023

1). Overall, the retrospective analysis showed that individual cases would have greatly benefited from the quantitative and visual feedback of EviGUIDE. Conclusion The decision support software EviGUIDE provides guidance on individualized dose prescription and allows users clear communication of expected treatment outcome based on model predictions, and insights about trade-offs between local tumor control and organ at risk sparing. Utility and potential dose variation approaches should be tested prospectively in a clinical protocol. It can aid the dissemination of evidence-based knowledge about optimal treatment, and serve as a blueprint for other sites in RO.

Mini-Oral: Breast

MO-0135 A randomized trial of adjuvant hyperthermia to RT of locally advanced breast cancer, ESHO 1-85. J. Overgaard 1 , M.C. Hulshof 2 , O. Dahl 3 , G. Arcangeli 4